美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Global X China Biotech Innovation ETF

6.64

0.0000

成交量：- -

成交額：- -

市值：139.44萬

市盈率：- -

高：6.64

開：6.64

低：6.64

收：6.64

52周最高：6.64

52周最低：6.64

股本：21.00萬

流通股本：21.00萬

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

抗體浪潮風起，這家Biotech緊抓機遇

股海導航_2025年6月16日_滬深股市公告與交易提示

6月16日上市公司重要公告集錦：博眾精工擬4.2億元收購上海沃典70%股權

2025年6月16日漲停板早知道：七大利好有望發酵

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CHB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CHB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHB\",,,,,undefined,":{"symbol":"CHB","market":"US","secType":"STK","nameCN":"Global X China Biotech Innovation ETF","latestPrice":6.64,"timestamp":1739998800000,"preClose":6.64,"halted":0,"volume":0,"delay":0,"floatShares":210000,"shares":210000,"eps":0,"marketStatus":"盤後交易","change":0,"latestTime":"08-21 17:04:00 EDT","open":6.64,"high":6.64,"low":6.64,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1755820800000},"marketStatusCode":4,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":6.64,"sharesOutstanding":210000,"nav":6.72,"aum":1412042.9,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHB\",,,,,undefined,":{"symbol":"CHB","floatShares":210000,"roa":"--","roe":"--","lyrEps":0,"shares":210000,"dividePrice":0,"high":6.64,"amplitude":0,"preClose":6.64,"low":6.64,"week52Low":6.64,"pbRate":"--","week52High":6.64,"institutionHeld":0,"latestPrice":6.64,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":6.64,"prevYearClose":6.64,"prevWeekClose":6.64,"prevMonthClose":6.64,"prevQuarterClose":6.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CHB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-20","symbol":"CHB","reason":null,"defaultRemindTime":1708439400000,"announcedDate":"2024-02-16","type":"delisting","dateTimestamp":1708405200000},{"date":"2023-12-28","symbol":"CHB","amount":0.001878,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"Global X China Biotech Innovation ETF","recordDate":"2024-01-08","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-08"},{"date":"2023-06-29","symbol":"CHB","amount":0.037027,"announcedDate":"2023-06-28","type":"dividend","market":"US","newRecordDate":"2023-06-30","defaultRemindTime":1688045400000,"name":"Global X China Biotech Innovation ETF","recordDate":"2023-07-10","payableDate":"2023-06-30","currency":"USD","dateTimestamp":1688011200000,"payDate":"2023-07-10"},{"market":"US","date":"2022-06-29","symbol":"CHB","amount":0.019889,"defaultRemindTime":1656509400000,"name":"Global X China Biotech Innovation ETF","recordDate":"2022-07-08","payableDate":"2022-06-30","currency":"USD","type":"dividend","dateTimestamp":1656475200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CHB\",market:\"US\",,,undefined,":[{"executeDate":"2022-06-29","recordDate":"2022-06-30","paymentDate":"2022-07-08","value":0.019889,"currency":"USD"},{"executeDate":"2023-06-29","recordDate":"2023-06-30","paymentDate":"2023-07-10","value":0.037027,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-08","value":0.001878,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CHB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CHB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560929367","title":"抗體浪潮風起，這家Biotech緊抓機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2560929367","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560929367?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 06:24","pubTimestamp":1755383098,"startTime":"0","endTime":"0","summary":"Vir Biotechnology不得不忙起来。7月，这家Biotech启动了第四款抗肿瘤候选药物的临床研究，尽管作为核心管线慢性丁型肝炎疗法tobevibart，相关III期试验也处于患者招募阶段。不过，相较Biotech间的联合，Vir一以贯之选择“大树好乘凉”。2025年以来，Vir的股价跌幅超过40%。VIR-5500和VIR-5818均处于积极剂量递增阶段，Vir每三周对VIR-5818进行一次剂量研究。7月31日，Vir又为ECLIPSE 2招募到首位患者。值得注意的是，Vir还把tobevibart与elebsiran的大中华区权益授予腾盛博药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817062744a48cdf2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817062744a48cdf2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4018","BK4139","BK4504","CHB","BNTX","BK4551","BK4585","CHD","BK4535","LU1585245621.USD","BK4548","LU1430594728.SGD","BK4588"],"gpt_icon":0},{"id":"2543614187","title":"股海導航_2025年6月16日_滬深股市公告與交易提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2543614187","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543614187?lang=zh_tw&edition=fundamental","pubTime":"2025-06-16 07:07","pubTimestamp":1750028820,"startTime":"0","endTime":"0","summary":"　　永安药业晚间发布股票交易异动暨风险提示公告称，近期公司股价短期涨幅较大，已严重偏离大盘走势，存在较高的炒作风险。2025年一季度，公司处于亏损状态。　　华海药业晚间公告，公司近日收到国家药监局核准签发的富马酸喹硫平缓释片的《药品注册证书》。交易完成后，公司持有上海沃典70%股权。此次中标项目系公司在核电领域的首个订单。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-06-16/doc-infafies1199709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CHB","LU1878469433.USD","BK4141","PI"],"gpt_icon":0},{"id":"2543961847","title":"6月16日上市公司重要公告集錦：博眾精工擬4.2億元收購上海沃典70%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2543961847","media":"证券日报","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543961847?lang=zh_tw&edition=fundamental","pubTime":"2025-06-15 21:10","pubTimestamp":1749993039,"startTime":"0","endTime":"0","summary":"6月16日上市公司重要公告集锦：博众精工拟4.2亿元收购上海沃典70%股权","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506153430875170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PI","BK4141","CHB","LU1878469433.USD"],"gpt_icon":0},{"id":"2543841618","title":"2025年6月16日漲停板早知道：七大利好有望發酵","url":"https://stock-news.laohu8.com/highlight/detail?id=2543841618","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543841618?lang=zh_tw&edition=fundamental","pubTime":"2025-06-15 20:08","pubTimestamp":1749989280,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　6月15日消息，有七大利好可能影响明日股市，具体为：。　　华海药业晚间公告，公司近日收到国家药监局核准签发的富马酸喹硫平缓释片的《药品注册证书》。富马酸喹硫平缓释片用于治疗精神分裂症和双相情感障碍的抑郁发作。　　6月14日，深交所上市公司安徽安利材料科技股份有限公司公示最新一期的投资者关系活动记录表。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-06-15/doc-infaefte1791150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4141","LU1878469433.USD","PI","CHB"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CHB\",params:#limit:6,delay:false,,,undefined,":[]}}